Is there a generic version of Advair Diskus available? Yes. The following products are equivalent to Advair Diskus: FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (fluticasone propionate; salmeterol xinafoate powder;inhalation) Manufacturer: HIKMA Approval date: December 17, 2020

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in...

2025年1月23日 · Generic name: fluticasone and salmeterol [ floo-TIK-a-sone, sal-ME-te-rol ] Brand names: Advair Diskus, Advair HFA, AirDuo RespiClick Drug class: Bronchodilator combinations. Medically reviewed by Kaci Durbin, MD. Last updated on Jan 23, 2025. Uses; Warnings; Before taking; Dosage; Side effects; Interactions; FAQ; What is Advair?

2019年1月31日 · The Food and Drug Administration (FDA) has approved Mylan's Wixela Inhub, the first generic version of Advair Diskus (fluticasone propionate and salmeterol inhalation powder; GlaxoSmithKline)...

The Wixela™ Inhub™ device has been developed as a generic equivalent of Advair Diskus ®, and provides a combination treatment for patients with asthma whose symptoms are not controlled with inhaled corticosteroids alone and for those with chronic obstructive pulmonary disease (COPD) who are at a high risk for exacerbations. We provide ...

Save money on your Advair Diskus® prescription by switching to Teva's FDA-approved generic version, Fluticasone Propionate and Salmeterol Inhalation Powder, USP

2019年2月5日 · Wixela™ Inhub™ is the first FDA-approved therapeutically equivalent generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or chronic obstructive pulmonary disease (COPD)

Learn about ADVAIR for the treatment of asthma and ADVAIR DISKUS 250/50 for COPD, including risks and side effects.

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary ...

2019年2月1日 · The US Food and Drug Administration (FDA) has approved Mylan’s generic version of GlaxoSmithKline’s (GSK) asthma treatment Advair Diskus (fluticasone propionate and salmeterol inhalation powder). Dubbed Wixela Inhub, Mylan’s treatment is …